InvestorsObserver
Sign Up Login

PKI Perkinelmer

$131.35 $3.22 (2.51%)
Add to Watchlist Compare
Overall

PKI Stock Analysis Overview

What this means: Perkinelmer (PKI) gets an Overall Rank of 54, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. PKI's 54 means that it ranks higher than 54% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

PKI Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

PKI Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

PKI Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

PKI Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

PKI Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

PKI Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

PKI Stock Analysis Overview

What this means: Perkinelmer (PKI) gets an Overall Rank of 54, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. PKI's 54 means that it ranks higher than 54% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full PKI report

PKI Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

PKI Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

PKI Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

PKI Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

PKI Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

PKI Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Perkinelmer (PKI) Analyst Forecast

PKI Price, Volume, Earnings, and Dividend Date

  • Last Price $131.35
  • Previous Close $128.13
  • Change $3.22
  • Open $126.14
  • Volume 769,798
  • Avg. Volume (100-day) 729,022
  • Market Cap 16,579,515,044
  • Days Range 125.57 - 131.89
  • 52-week Range 116.18 - 203.16
  • Dividend Yield 0.22%
  • Ex. Dividend Date 10/20/22
  • P-E 23.9
  • EPS 5.36000013
  • Earnings Date 11/01/22
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Avg. Analyst Rec. Premium
  • Beta 1.179
  • PEG Ratio 0.33

Perkinelmer (PKI) Company Description

PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Perkinelmer (PKI) Stock Chart

View Interactive PKI chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Diagnostics & Research

Company Price
Akumin Inc (AKU) (AKU) $1.94
Aclaris Therapts (ACRS) (ACRS) $15.75
Inotiv Inc (NOTV) (NOTV) $20.92
Neuronetics Inc (STIM) (STIM) $3.33
Danaher Corp (DHR) (DHR) $282.29
Guardant Health Inc (GH) (GH) $59.78
Biodesix Inc (BDSX) (BDSX) $1.54
Bionano Genomics Inc (BNGO) (BNGO) $2.19
Radnet Inc (RDNT) (RDNT) $20.31
Meridian Bioscience (VIVO) (VIVO) $31.93